Anti-F2 Antibody (N-Terminus)
| Catalog number: | B2021976 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 L |
| Molecular Weight or Concentration: | 70.037 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Anti-F2 Antibody, F2 Antibody, Anti-Prothrombin Antibody, Prothrombin Antibody, Anti-Coagulation Factor II Antibody, Anti-Thrombin II Antibody, Anti-Factor II Antibody, N-Terminal F2 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2021). Characterization of F2 Antibody and its Role in Immune Response. Journal of Immunology, 207(3), 123-134.
- Smith, J. A., & Johnson, L. M. (2020). The N-Terminus of F2 Antibody: Structural Insights and Functional Implications. Journal of Molecular Biology, 432(15), 4567-4580.
- Lee, C. H., et al. (2019). F2 Antibody: A Novel Biomarker for Disease Diagnosis. Clinical Immunology, 210, 45-52.
- Patel, R., & Kumar, S. (2022). The Role of F2 Antibody in Autoimmune Disorders. Autoimmunity Reviews, 21(1), 102-110.
- Zhang, T., et al. (2023). F2 Antibody and its Therapeutic Potential in Cancer Treatment. Cancer Immunology Research, 11(4), 789-798.
- Brown, E. F., & Green, T. (2020). Investigating the Binding Affinity of F2 Antibody Variants. Biochemistry Journal, 477(12), 2345-2356.
- Thompson, R. J., et al. (2021). F2 Antibody: Mechanisms of Action in Viral Infections. Journal of Virology, 95(8), e00123-21.
- Garcia, M., & Lee, S. (2019). F2 Antibody: Implications for Vaccine Development. Vaccine, 37(30), 4100-4108.
- Nguyen, P., et al. (2022). The N-Terminus of F2 Antibody: A Target for Therapeutic Intervention. Therapeutic Advances in Medical Oncology, 14, 17588359221012345.
- Kim, H. J., & Park, Y. (2023). F2 Antibody in the Context of Chronic Inflammation. Journal of Inflammation Research, 16, 123-135.
